戻る Agenda
Session 7: Track A: International Collaborations and Updates
Session Chair(s)
Ed Morgan
Director General, Policy, Planning and International Affairs Directorate, HPFB, Health Canada, Canada
This session will outline the importance of collaborating internationally to help protect and enhance the health of Canadians. The purpose of this session is to provide an update on international collaborative files including, but not limited to: Regulatory Cooperation Council (RCC), Comprehensive Economic and Trade Agreement (CETA), European Union, Trans-Pacific Partnership (TPP) etc.; Update on International Council for Harmonisation (ICH); Update on medical devices; Industry perspective.
Speaker(s)
Mary Hill
Manager, International Unit, Health Canada, Canada
Health Canada’s International Collaboration with Regulatory Counterparts
Michelle Limoli, PHARMD, RPH
Associate Director, International Programs, FDA, United States
Overview: ICH Training Activities and APEC Regulatory Harmonization Steering Committee
Celia Lourenco, PHD
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada, Canada
International Collaboration: ICH and IPRP